Clinical Trials Directory

Trials / Terminated

TerminatedNCT03152292

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

Management of Parkinson's Disease Psychosis in Actual Practice (The INSYTE Study)

Status
Terminated
Phase
Study type
Observational
Enrollment
764 (actual)
Sponsor
ACADIA Pharmaceuticals Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To examine the current disease progression of PDP, the clinical, economic, and humanistic impact of anti-psychotic therapy in the management of the condition in real-world settings, and the burden of the condition on patients and their caregivers

Conditions

Interventions

TypeNameDescription
OTHERReal-world, non-interventionalN/A - non-interventional

Timeline

Start date
2017-03-30
Primary completion
2021-03-08
Completion
2021-03-08
First posted
2017-05-15
Last updated
2021-08-06

Locations

69 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03152292. Inclusion in this directory is not an endorsement.

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study (NCT03152292) · Clinical Trials Directory